SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
胖胖鱼
Lv1
30 积分
2024-04-11 加入
最近求助
最近应助
互助留言
2022 update of the drug resistance mutations in HIV-1
3天前
已完结
Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment–Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials
10天前
已完结
Comparison of the efficacy, safety and durability of a switch to co-formulated RPV/TDF-TAF/FTC or DTG/ABC/3TC in virologically-suppressed HIV-1-infected patients in a single Italian centre: a cohort data analysis
12天前
已完结
An up-to-date evaluation of dolutegravir/abacavir/lamivudine for the treatment of HIV
18天前
已完结
Single tablet regimen with abacavir/lamivudine/dolutegravir compared with two-drug regimen with lamivudine and dolutegravir as different strategies of simplification from a multicenter HIV cohort study
18天前
已关闭
Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon
18天前
已完结
Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial
19天前
已完结
没有进行任何应助
感谢,点赞
3天前
感谢,速度真快
10天前
感谢,速度真快
11天前
感谢,点赞
18天前
不需要这篇文献了【积分已退回】
18天前
感谢,点赞
18天前
感谢
19天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论